Drug immunogenicity may generate significant hypersensitivity reactions that may progress to the development of auto-antibodies to the patient's natural version of that protein.
Use our well-characterized immunospecific reagents to:
Investigate baseline or pretherapy immune response
Detect post-therapy titer increases
Screen for neutralizing antibodies
Correlate antibody titer to response to therapy
Map epitopes of the immunogenic portion of a drug
Distinguish between immunogenicity of a therapeutic drug and the natural form of the protein
Distinguish between immune response to a drug and process contaminants, such as host cell proteins
Isotype and subtype antibodies involved in the immunogenic response
